The company has gained FDA approval for its Exablate Neuro system for use with 1.5T MRI in the non-invasive treatment of essential tremor (ET) in patients who have not responded to medication.

The device uses focused ultrasound waves to target and ablate the thalamus with no surgical incisions or implants.

The MRI-guided treatment allows for real-time monitoring. — Cynthia Jessup